Cervical cancer prevention and hormonal contraception

Lancet

Volumn 370, Issue 9599, 2007, Pages 1591-1592

  Sasieni, Peter ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; WART VIRUS VACCINE;

ARTICLE; CANCER INVASION; CANCER PREVENTION; CANCER REGRESSION; CANCER RISK; CANCER SCREENING; CONDOM; DRUG MECHANISM; FUNDING; HORMONAL CONTRACEPTION; HUMAN; NONHUMAN; ORAL CONTRACEPTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS; WOMEN'S HEALTH;

EID: 35748930222     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)61667-5     Document Type: Note

References (12)

1. Cogliano V., Grosse Y., Baan R., et al. Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment. Lancet Oncol 6 (2005) 552-553
2. Skegg D. Oral contraceptives, parity, and cervical cancer. Lancet 359 (2002) 1080-1081
3. International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cancer from 24 epidemiological studies. Lancet 370 (2007) 1609-1621
4. Winer R., Hughes J., Feng Q., et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 354 (2006) 2645-2654
5. Hogewoning C., Bleeker M., van den Brule A., et al. Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial. Int J Cancer 107 (2003) 811-816
6. Milam M., Pollock J., Nick A., et al. The effect of hormonal contraception on the adequacy of colposcopic examination of the cervix. Am J Obstet Gynecol 192 (2005) 1368-1369
7. Morrison C., Bright P., Wong E., et al. Hormonal contraceptive use, cervical ectopy, and the acquisition of cervical infections. Sex Transm Dis 31 (2004) 561-567
8. Mitrani-Rosenbaum S., Tsvieli R., and Tur-Kaspa R. Oestrogen stimulates differential transcription of human papillomavirus type 16 in SiHa cervical carcinoma cells. J Gen Virol 70 (1989) 2227-2232
9. Stopinska-Gluszak U., Waligóra J., Grzela T., et al. Effect of estrogen/progesterone hormone replacement therapy on natural killer cell cytotoxicity and immunoregulatory cytokine release by peripheral blood mononuclear cells of postmenopausal women. J Reprod Immunol 69 (2006) 65-75
10. Riley R., Duensing S., Brake T., Münger K., Lambert P., and Arbeith J. Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis. Cancer Res 63 (2003) 4862-4871
11. Brake T., and Lambert P. Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model. Proc Natl Acad Sci USA 102 (2005) 2490-2495
12. International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16 563 women with cervical carcinoma and 33 542 women without cervical carcinoma from 25 epidemiological studies. Int J Cancer 119 (2006) 1108-1124